Acquired resistance mechanisms to afatinib in HER2‐amplified gastric cancer cells

Cancer treatment, especially that for breast and lung cancer, has entered a new era and continues to evolve, with the development of genome analysis technology and the advent of molecular targeted drugs including tyrosine kinase inhibitors. Nevertheless, acquired drug resistance to molecular targete...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cancer Sci
Päätekijät: Yoshioka, Takahiro, Shien, Kazuhiko, Takeda, Tatsuaki, Takahashi, Yuta, Kurihara, Eisuke, Ogoshi, Yusuke, Namba, Kei, Torigoe, Hidejiro, Sato, Hiroki, Tomida, Shuta, Yamamoto, Hiromasa, Soh, Junichi, Fujiwara, Toshiyoshi, Toyooka, Shinichi
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2019
Aiheet:
Original Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6676122/
https://ncbi.nlm.nih.gov/pubmed/31162771
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14089
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia